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Transcription factor 7-like 2 has been shown to be associated with type 2 diabetes mellitus in multiple ethnic groups
in recent years. In the Chinese Han population in particular, numerous studies have evaluated the association
between the rs11196218A/G polymorphism of the transcription factor 7-like 2 gene and type 2 diabetes mellitus.
However, the results have been inconsistent, so we performed a meta-analysis to assess the association. Odds ratio
and 95% confidence interval values were calculated using a random-effects model or a fixed-effects model based on
heterogeneity analysis. The quality of the included studies was evaluated using the Newcastle-Ottawa Scale.
Subgroup analyses were conducted based on conformity with Hardy-Weinberg equilibrium in the control group as
well as on other variables, such as age, sex and body mass index. Sensitivity analysis was also performed to detect
heterogeneity and to assess the stability of the results. In total, 10 case-control studies comprising 7,491 cases and
12,968 controls were included in this meta-analysis. The combined analysis indicated that the rs11196218A/G
polymorphism was not associated with type 2 diabetes mellitus (G vs. A, OR=1.04, 95% CI=0.97-1.13, p=0.28). The
subgroup analyses also did not show any association between the rs11196218A/G polymorphism and the risk of type
2 diabetes mellitus. Furthermore, the results of the subgroup analyses indicated that the absence of an association
was not influenced by age, sex or body mass index. The results of the sensitivity analysis verified the reliability and
stability of this meta-analysis. In conclusion, this study indicated that there is no significant association between the
rs11196218A/G polymorphism and the risk of type 2 diabetes mellitus in the Chinese Han population.
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Type 2 diabetes mellitus (T2DM) is a complex metabolic
disease resulting from a combination of environmental and
genetic factors (1). With the development of society and the
improvement of people’s standard of living, the prevalence
of T2DM is increasing rapidly all around the world. T2DM is
very harmful to human health and life, and it also confers a
heavy burden on society.
The transcription factor 7-like 2 (TCF7L2) gene, located on
chromosome 10q25 (2), is part of the Wnt signaling pathway (3)
and has been shown to be strongly associated with an increased
risk of T2DM in Icelandic (4), European (5-11), West African (12),
southern Asian (13), eastern Asian (14), and Chinese (15-19)
populations. The TCF7L2 gene is regarded as one of the most
important genes for determining genetic susceptibility to T2DM
that has been identified in humans so far.
With the growth of research efforts, studies on the association
between this variation and T2DM have been extensively
performed in China, but the results are disputable. Overall,
the most significant risk locus identified in Chinese individuals
is rs11196218. Therefore, only the rs11196218A/G polymorph-
ism was considered in the present meta-analysis.
In contrast to a single study, meta-analyses are based on all
available studies, which has improved the statistical power
for exploring the above associations and has led to more
reliable conclusions in recent years (20). Therefore, in the
present study, a meta-analysis was performed to allow a
valuable conclusion to be drawn regarding the relationship
between the rs11196218A/G polymorphism and T2DM risk
in the Chinese Han population.DOI: 10.6061/clinics/2015(08)10
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’ MATERIALS AND METHODS
Our study adhered to the PRISMA Statement regarding
the reporting of systematic reviews and meta-analyses (21).
Search strategy
In this meta-analysis, we searched articles in PubMed,
Elsevier, SpringerLink, Embase, the Cochrane Library, ISI
Web of Science, Google Scholar and the China National
Knowledge Infrastructure (CNKI). The search languages
included English and Chinese. The following key words and
subject terms were used: TCF7L2, transcription factor 7-like
2, rs11196218, diabetes mellitus, type 2, type 2 diabetes
mellitus, T2DM, and T2D. The reference lists of eligible
studies and relevant review papers were additionally
identified via a manual search on this topic. The last research
update was performed on July 15, 2014.
Inclusion and exclusion criteria
The primary studies included in our meta-analysis had to
meet the following criteria: (1) the association between
the TCF7L2 polymorphism (rs11196218) and T2DM risk in
the Chinese Han population was clearly evaluated, (2) the
diagnosis of T2DM and the sources of the cases and controls
were clearly described, (3) a case-control study design was
employed, and (4) original data and sufficient information
were provided to estimate the odds ratio (OR) and the
corresponding 95% confidence interval (95% CI). The major
reasons for exclusion were as follows: (1) duplicate data were
presented; (2) the article consisted of an abstract, comment, or
review or focused on pathological mechanisms; and (3) more
than one article was published by the same author using the
same data series, in which case the most recent published
paper or the paper with the largest sample size was selected.
Quality assessment
The Newcastle-Ottawa Scale (NOS) (22) was used to assess
the quality of the studies included in our meta-analysis. The
NOS contains eight items and is categorized into three
dimensions: selection, comparability and exposure, for
case-control studies. In particular, the selection dimension
contains four items, the comparability dimension contains
one item, and the exposure dimension contains three items.
A star system is used to allow semi-quantitative assessment
of study quality, and a study can be awarded a maximum of
one star for each numbered item within the selection and
exposure categories. Meanwhile, a maximum of two stars
can be given for comparability. The NOS ranges from zero up
to nine stars, as follows: high-quality study: more than seven
stars; medium-quality study: between four and six stars;
poor-quality study: less than four stars.
Data extraction
For quality control, the data were extracted by two
reviewers using a standardized extraction form. If the
information on the genotype distribution was inadequate,
we tried to contact the authors by telephone or e-mail. The
following information was extracted from each article:
the last name of the first author, the year of publication,
the region, the numbers of cases and controls, the source of
the controls, the numbers of genotypes for cases and
controls, matching factors, and the Hardy-Weinberg equili-
brium (HWE) in each control group. Disagreement was
resolved by consulting a third reviewer.
Ethics statement
This article reports a meta-analysis of data obtained from
previous studies. All of the data were anonymized before
analysis. We also confirmed that none of the data involved
competing interests.
Statistical analysis
In this meta-analysis, OR and 95% CI values were used to
assess the association between a polymorphism of the
TCF7L2 gene (rs11196218: G vs. A) and T2DM risk. In
addition, statistical significance was assessed using a Z-test,
and po0.05 indicated statistical significance for the associa-
tion. The model selection was based on the heterogeneity
test; therefore, the w2-based Q-test was performed in this
study (23). When the Q-test yielded a p-value of more
than 0.10, a fixed-effects model was used (24); otherwise,
a random-effects model was applied (25). Heterogeneity
was also assessed using the I2 test. The I2 statistic was
specifically documented for the percentage of study
variability observed due to heterogeneity rather than
chance (I2= 0-25%, no heterogeneity; I2= 25-50%, moderate
heterogeneity; I2= 50-75%, high heterogeneity; I2= 75-100%,
extreme heterogeneity) (26).
Subgroup analyses were performed based on HWE.
Specifically, the p-values for HWE in the control group were
determined using the Pearson chi-square test, regardless of
whether the authors provided these values. HWE is the
principal law of population genetic studies: if p40.05,
the focus conforms to HWE, and the control samples are
representative. In Europeans, when excessive calories
are consumed, variation in TCF7L2 can cause impaired
b-cell function, indicating that body mass index (BMI) can
influence the effect size of TCF7L2 variants; hence, these two
Figure 1 - Selection of the included studies.
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factors will ultimately affect each other (27-29). This
interaction may also exist in Asians. For this reason, we
considered whether age, sex and BMI were matched between
cases and controls in our subgroup analyses. For example,
the studies showing a significant difference in age (po0.05)
between the cases and the controls were assigned to the
incomparability subgroup of age, whereas those exhibiting
p40.05 were assigned to the comparability subgroup.
However, due to the limited data in the studies, subgroup
analyses based on environment were not conducted.
Sensitivity analysis was also performed to search for
heterogeneity and to assess the stability of the results. One
case-control study was omitted each time to reflect the
influence of each dataset on the pooled OR.
Additionally, funnel plots were used to evaluate publica-
tion bias. All p-values were two tailed. Review Manager 5.0
(2011, The Cochrane Collaboration) software was used to
perform the meta-analysis.
’ RESULTS
Studies and data included in this meta-analysis
In total, 295 articles were relevant to our search terms, of
which 285 papers were excluded. Thus, 10 case-control
studies (15-19,30-34) comprising 7,491 cases of T2DM and
12,968 controls were ultimately included in this meta-
analysis (Figure 1). All of these studies were published from
2007-2014.
The characteristics of these studies are summarized in
Table 1. The genotype frequency of the single nucleotide
polymorphism (SNP) was consistent with HWE in the
control group (p40.05) in all studies except for two (32,33).
The quality assessment of all included studies, evaluated
according to the NOS, is provided in Table 2. Most studies
were of high quality in terms of selection and exposure.
However, the quality of comparability was relativity low, as
only 3 studies (15,33,34) were comparable with the controls
regarding age, sex and BMI.
Association between rs11196218A/G polymorphism
and T2DM risk
Using the heterogeneity test, we detected heterogeneity
among the studies in comparisons of the risk of carrying
allele G. Thus, a random-effects model was applied for the
meta-analysis. The results indicated that the rs11196218A/G
polymorphism was not associated with the risk of T2DM
(G vs. A: OR=1.04, 95% CI=0.97-1.13, p=0.28; heterogeneity
test w
2
= 17.71, p = 0.04, I2=49%; Figure 2).
The subgroup meta-analysis of the studies that exhibited
consistency with HWE in the control group also showed that
there was no association between the rs11196218A/G
polymorphism and T2DM risk (G vs. A: OR= 1.08, 95%
CI = 0.98-1.19, p = 0.12; heterogeneity test w
2
= 15.79, p= 0.03,
I2=56%; Figure 3).
The subgroup meta-analysis of the studies based on age
indicated that there was no significant association between
the rs11196218A/G polymorphism and T2DM risk (sub-
group of age comparability: OR= 1.11, 95% CI = 0.96-1.28,
p= 0.18; heterogeneity test w
2
= 14.81, p = 0.01, I2= 66%; sub-
group of age incomparability: OR= 1.00, 95% CI = 0.94-1.06,
p=0.93; heterogeneity test w
2
= 1.45, p = 0.69, I2=0%).
The subgroup meta-analysis of the studies based on sex
demonstrated that there was no significant association
between the rs11196218A/G polymorphism and T2DM
risk (subgroup of sex comparability: OR = 1.10, 95% CI =
0.98-1.24, p = 0.12; heterogeneity test w
2
= 13.04, p = 0.02,
I2 = 62%; subgroup of sex incomparability: OR= 0.98, 95%
CI = 0.91-1.05, p = 0.49; heterogeneity test w
2
= 1.58, p = 0.66,
I2 = 0%).
Finally, the subgroup meta-analysis of the studies based on
BMI illustrated that there was no significant association
between the polymorphism and T2DM risk (subgroup of







Sample sizes Cases Controls HWE Comparability
Case Control G A G A
Ng 2007 Hong Kong Community-based and
hospital staff
433 419 676 190 599 239 Yes Age*, sex*, BMI**
Zhang 2008 Hunan Hospital-based 536 475 716 272 623 221 Yes Age*, sex**, BMI*
Luo 2009 Beijing Hospital-based 500 500 684 252 696 240 No Age**, sex**, BMI**
Ma 2010 Shanghai Hospital-based 259 200 309 209 240 168 Yes Age**, sex*, BMI**
Lin 2010 Chengdu Hospital-based 1529 1439 2171 887 2015 863 Yes Age**, sex*, BMI**
Wen 2010 Shanghai N/D 1165 1136 1699 629 1677 595 No Age*, sex*, BMI*
Zhu 2011 Anhui Hospital-based 300 300 156 444 122 478 Yes Age*, sex*, BMI*
Zheng 2012 Chongqing Hospital-based 227 152 340 114 218 86 Yes Age*, sex**, BMI**
Qiao 2012 Harbin Hospital-based 700 560 1025 367 819 295 Yes Age*, sex*, BMI*
Zhai 2014 Henan Community-based
and Hospital-based
1842 7777 2639 967 111287 4041 Yes Age**, sex**, BMI**
Abbreviations: HWE, Hardy-Weinberg equilibrium; Yes, the genotype distribution conformed to HWE in the control group; No, the genotype distribution
not conform to HWE in the control group;
Hospital-based: subjects who were enrolled from health checks conducted at the hospital; community-based and hospital staff: subjects who were
enrolled from the community and hospital staff; N/D: no description; *: p40.05; **: po0.05.
Table 2 - Quality assessment of all of the included studies.
First author Publication year Selection Comparability Exposure
Ng 2007 $$$ $ $
Zhang 2008 $$ $ $$
Luo 2009 $$ $ $$
Ma 2010 $$ $ $$
Wen 2010 $$ $$ $$$
Lin 2010 $$ $ $$
Zhu 2011 $$$$ $$ $$
Zheng 2012 $$$$ $ $$
Qiao 2012 $$$ $$ $
Zhai 2014 $$ $ $$
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BMI comparability: OR= 1.03, 95% CI = 0.90-1.17, p= 0.72;
heterogeneity test w
2
= 6.21, p = 0.10, I2= 52%; subgroup of
BMI incomparability: OR= 1.06, 95% CI = 0.96-1.18, p= 0.26;
heterogeneity test w
2
= 11.32, p= 0.05, I2= 56%).
Sensitivity analysis
A single study included in the meta-analysis was omitted
each time to reflect the influence of each dataset on the
pooled OR values. We found that no single study could
change the pooled results (Table 3), which indicated that the
results were relatively reliable.
Publication bias
The shape of the funnel plots was symmetrical, suggesting
that there was no evidence of publication bias for the
rs11196218A/G polymorphism (Figure 4).
’ DISCUSSION
Since the initial discovery that TCF7L2 is strongly associated
with an increased risk of T2DM in Icelandic populations in
2006 (4), many replication studies have confirmed the role of
TCF7L2 in conferring susceptibility to T2DM in different
populations and ethnic groups (5,7,11,14,38,39), especially for
the rs7903146C/T polymorphism. However, in the Chinese
population, rs7903146 is very rare, and several studies have
indicated that rs11196218 is the most significant risk variant
(17). Nevertheless, the results regarding the rs11196218A/G
polymorphism and T2DM risk have been inconsistent for the
Chinese Han population. Certain studies (15-19) confirmed that
the G allele of the rs11196218A/G polymorphism was
significantly associated with T2DM risk, whereas studies by
Ma (30), Zheng et al. (31), Luo et al. (32), Wen et al. (33) and
Qiao et al. (34) did not find a significant association between
the rs11196218A/G polymorphism and T2DM risk in the
Chinese Han population. Therefore, to resolve the conflict
among these studies, we performed a meta-analysis to assess
the association between the rs11196218A/G polymorphism
and T2DM risk.
Previously, Luo et al. (32) conducted a meta-analysis to
evaluate the effect of TCF7L2 on genetic susceptibility to
T2DM in the East Asian population. However, only one
article analyzed included samples from the Chinese Han
population. In the current study, to increase the statistical
power of the analysis, a larger amount of data was collected
from the literature to perform an up-to-date meta-analysis
for the Chinese Han population.
Our meta-analysis, which included 7,491 T2DM cases and
12,968 controls from 10 case-control studies, explored the
association between rs11196218A/G and T2DM risk. Overall,
Figure 2 - Meta-analysis of the association between the rs11196218A/G polymorphism and T2DM risk (G vs. A). n indicates the total
number of G alleles, and N indicates the total number of G alleles plus A alleles.
Figure 3 -Meta-analysis of the association between the rs11196218A/G polymorphism and T2DM risk (subgroup analyses for HWE in the
control group: G vs. A). n indicates the total number of G alleles, and N indicates the total number of G alleles plus A alleles.
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we did not find that the rs11196218A/G polymorphism was
significantly associated with an increased risk of T2DM in
the Chinese Han population, which is consistent with the
findings of Ma (30), Zheng et al. (31), Luo et al. (32), Wen et
al.(33) and Qiao et al. (34). However, a previous meta-
analysis performed by Luo et al. (32) found that rs11196218
showed a marginal association with T2DM risk (OR= 1.09,
95% CI = 1.00-1.19, p= 0.059). The most plausible explanation
for this discrepancy is the different genetic backgrounds
associated with different ethnic groups, areas and population
substructures.
In the present study, obvious heterogeneity was observed
in the comparisons among studies. Thus, a random-effects
model was applied for the meta-analysis, after which we
conducted a sensitivity analysis to identify the source of the
heterogeneity. After omitting the study by Ng et al. (17) from
the analysis, there was no heterogeneity among the
remaining studies. One plausible explanation for the
influential role of this study was that the populations
examined by Ng et al. (17) resided in the metropolis of Hong
Kong; as the residents of Hong Kong emigrated from
different areas of China, they have probably undergone
population admixture. Moreover, T2DM is a complex
hereditary disease, so the historical immigration, complex
ancestries, population movement, and recent intermarriages
with other ethnic groups that have occurred in Hong Kong
may have resulted in different risk factors in different people
(40). Therefore, the genetic origins of risk may be relatively
different between this region and other areas. Pritchard et al.
(41) also suggested that low diversity may be sufficient to
lead to different results. However, although heterogeneity
was observed among studies, the results of the sensitivity
analysis verified the reliability and stability of the present
meta-analysis.
T2DM is a complex hereditary disease caused by
genetic and environmental factors (1). Other confound-
ing factors, such as age, sex, BMI, the environment
and sophisticated gene-gene and gene-environment
interactions, may also affect the results of studies on
T2DM. Thus, the subgroup analyses in the present study
were also conducted based on variables such as age, sex
and BMI. However, the results indicated that the
association of the rs11196218A/G polymorphism with
T2DM was not influenced by age, sex or BMI in the
studied population. Due to the limited data available in
the studies analyzed, subgroup analyses based on the
environment and gene-gene and gene-environment inter-
actions were not conducted.
There were certain advantages of our meta-analysis.
First, to the best of our knowledge, this is the most
comprehensive meta-analysis of the association between
the rs11196218A/G polymorphism of the TCF7L2 gene
and T2DM risk in the Chinese Han population conducted
to date, and our analysis had improved statistical power
for exploring this association. Second, the protocol for this
meta-analysis, using explicit methods and criteria for
study selection, data extraction, and data analysis, was
well designed before it was initiated. Third, a stringent
searching strategy based on computer-assisted and man-
ual searches was applied to include as many eligible
studies as possible. Finally, the quality of the studies
included in our meta-analysis was satisfactory; in fact,
each article exhibited at least five stars. However, there
were still certain limitations of this meta-analysis. First, the
sample sizes of several of the studies included in our meta-
analysis were relatively small. Second, due to the limited
Table 3 - The results of the sensitivity analysis with each rs1119
6218A/G-focused study omitted.
Study omitted OR 95% CI p-value
Lin et al. 1.01 0.96-1.07 0.62
Luo et al. 1.03 0.98-1.08 0.32
Ma et al. 1.02 0.97-1.07 0.44
Ng et al. 1.00 0.95-1.05 0.90
Qiao et al. 1.02 0.97-1.07 0.41
Wen et al. 1.03 0.98-1.09 0.26
Zhai et al. 1.04 0.98-1.11 0.16
Zhang, Y. 1.03 0.98-1.08 0.32
Zheng et al. 1.02 0.97-1.07 0.50
Zhu, H. 1.01 0.96-1.06 0.69
Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 4 - Funnel plot analysis to detect publication bias (G vs. A of the rs11196218A/G polymorphism). Each point represents an
independent study on the indicated association. The dark point represents two overlapping articles.
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information on environment and lifestyle available the
included studies, it was not possible to perform a
subgroup meta-analysis or an interaction analysis based
on environment or lifestyle. Finally, similar to a case-
control study, a meta-analysis is a retrospective study, and
recall bias might also exist.
In conclusion, we did not find any association between the
TCF7L2 gene rs11196218A/G polymorphism and T2DM risk
in the Chinese Han population. To achieve a better and more
comprehensive understanding of the association between
TCF7L2 gene polymorphisms and T2DM risk, we suggest
that studies including large samples and different ethnicities
and lifestyles and examining sophisticated gene-gene and
gene-environment interactions should also be considered in
future analyses.
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